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Spinal and bulbar muscular atrophy (SBMA) is a motor neuron disease (MND) caused by 
a polyglutammine expansion in the androgen receptor (ARpolyQ) protein that interferes 
with the correct folding of the protein. Indeed, when ARpolyQ is activated by testosterone, 
it is released by the Heat Shock proteins and misfolds. In presence of misfolded proteins 
cells activate the protein quality control (PQC) system that is composed by a chaperone 
network, responsible for the refolding of proteins, and by two main degradative system the 
ubiquitin proteasome system (UPS) and the autophagy lysosome pathway (ALP). When 
chaperone system fails, misfolded proteins are addressed to the degradative pathways. If 
misfolded proteins are not correctly removed, they could aggregate in insoluble high 
molecular weight species. These inclusions are found in patient nervous system. Despite 
of being a MND recent data suggest that ARpolyQ exert toxicity also on skeletal muscle. 
Thus in this study we used muscle C2C12 cells stably trasfected with the AR carrying a 
tract of 100 glutammine to study the PQC system involvement in muscle during the 
disease. 
Initially, we characterized the cellular model and by filter trap assay (FTA) we found that 
ARpolyQ accumulated after testosterone treatment. We also observed that after activation 
ARpolyQ is present in the insoluble NP-40 fraction. We inhibited the degradative pathways 
and observed that ARpolyQ is degraded by both UPS and ALP. As activators of the UPS 
are highly toxic we enhanced ALP with trehalose. We observed that trehalose treatment 
significantly reduced the accumulation of ARpolyQ. By real time PCR we observed that 
trehalose increased the expression of many ALP-related genes such as HspB8. HspB8 is 
a small heat shock protein that acts in the refolding of proteins or addresses them to ALP. 
We overexpressed HspB8 and found that it reduced ARpolyQ accumulation, while 
silencing HspB8 increased the accumulation in FRA. 
These results demonstrate that modulating autophagy could be a promising therapeutical 
strategy for disease associated to misfolded and aggragated protein like SBMA. 
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